EUVIMEDEUVIMED entdecken
Crossref

Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area

Hans E. Johnsen, Bo Björkstrand, Tobias W. Klausen, Kari Remes, Astrid Gruber, Lene M. Knudsen, Olav J. Bergmann, Stig Lenhoff

Hematology Reports · 2009

DOI: 10.4081/hr.2009.e2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology Reports, 2009. Verfasst von Hans E. Johnsen und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Johnsen, H. E., Björkstrand, B., Klausen, T. W., Remes, K., Gruber, A., Knudsen, L. M., Bergmann, O. J., & Lenhoff, S. (2009). Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area. Hematology Reports. https://doi.org/10.4081/hr.2009.e2

Vancouver

Johnsen HE, Björkstrand B, Klausen TW, Remes K, Gruber A, Knudsen LM, et al. Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area. Hematology Reports. 2009. doi:10.4081/hr.2009.e2

BibTeX
@article{Johnsen2009,
  author = {Johnsen, Hans E. and Björkstrand, Bo and Klausen, Tobias W. and Remes, Kari and Gruber, Astrid and Knudsen, Lene M. and Bergmann, Olav J. and Lenhoff, Stig},
  title = {Double vs. single high dose melphalan 200 mg/m2 and autologous stem cell transplantation for multiple myeloma: a region-based study in 484 patients from the Nordic area},
  journal = {Hematology Reports},
  year = {2009},
  doi = {10.4081/hr.2009.e2}
}
Kostenlos starten →